(1)
Proposed partnership would focus on developing innovative, science-backed wellness products
Vancouver, British Columbia (Newsfile Corp. - May 25, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ( Emerald ) and The Uplifters Prima, PBC ( Prima ), based in Santa Monica, California, have signed a letter of intent (the LOI ) contemplating joint initiatives to co-develop new cannabinoid-based wellness products for sale in the United States, Canada, and internationally. As an initial step in establishing the relationship, Emerald has made a capital investment in Prima s current financing round of Series Seed-1 Preferred Stock.
Prima, formed in 2018, was created to serve consumers who prioritize holistic well-being using products based on credible science and emerging botanical discoveries, and formulated using blends of active plant-derived therapeutics and broad-spectrum hemp extract with naturally occurring CBD. In just two years, Prima has achieved exceptio
Emerald Health Therapeutics Licenses New Proprietary Cannabis Dried Flower Format Patent for use in United States streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Emerald Health Therapeutics, Inc.: Emerald Health Therapeutics Appoints Moe Jiwan as Chief Operating Officer
th.
Mr. Jiwan is a data-driven business leader with over 20 years of diverse experience in strategic development, sales and operations management, e-commerce, and developing data and business intelligence solutions. Before joining Emerald, he served in senior leadership positions, including chief information officer and chief customer officer, for established cannabis and health companies, including senior roles at TerrAscend Corp and Shopper s Drug Mart. With a strong marketing and customer orientation, he has strongly focused on operational excellence and implementing processes to function faster, smarter, and leaner.
Emerald has also appointed Mr. Francois St. Louis as Site Director of its St. Eustache facility in Quebec to provide operational leadership for this facility and team. He has an extensive background in production, operations and quality assurance. His most
Emerald Health Therapeutics, Inc.: Emerald Health Therapeutics Reports 2020 Year-end and Fourth Quarter Financial Results and Provides Corporate Update
11,740
(1,022
10,983 Recreational Recreational
287 Emerald EBITDA is calculated by subtracting realized and unrealized changes in fair value of biological assets, and adding back depreciation, share-based payments, impairment of assets, and inventories written down to Loss from operations.
Emerald s audited annual consolidated financial statements and management discussion and analysis for the 12 months ended December 31, 2020, together with other information related to Emerald, including Emerald s most recent annual information form, can be found on SEDAR. Additional information related to Emerald is available on its website at www.emeraldhealth.ca.
Emerald Health Therapeutics, Inc : Emerald Health Therapeutics Confirms Effective Listing Date on Canadian Securities Exchange finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.